22.418 articles found

PPAR: a therapeutic target in Parkinson's disease.

Chaturvedi RK, Beal MF.

J Neurochem · 2008-04-01

DOI: 10.1111/j.1471-4159.2008.05388.xPMID: 18384649

TREATMENT OF NEUROLOGICAL DISORDERS

HOVENS CHRISTOPHER.

· 2008-03-28

USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS

BERGMANN JOHN E, CUTSHALL NEIL S, DEMOPULOS GREGORY A, FLORIO VINCENT A, GAITANARIS GEORGE, GRAY PATRICK, HOHMANN JOHN, ONRUST RENE, ZENG HONGKUI.

· 2008-03-27

THE USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS

BERGMANN JOHN E, CUTSHALL NEIL S, DEMOPULOS GREGORY A, FLORIO VINCENT A, GAITANARIS GEORGE, GRAY PATRICK, HOHMANN JOHN, ONRUST RENE, ZENG HONGKUI.

· 2008-03-27

THE USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS

GRAY PATRICK, HOHMANN JOHN, CUTSHALL NEIL S, GAITANARIS GEORGE, BERGMANN JOHN E, ONRUST RENE, FLORIO VINCENT A, DEMOPULOS GREGORY A, ZENG HONGKUI.

· 2008-03-27

L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.

Mathias CJ.

Clin Auton Res · 2008-03-27

DOI: 10.1007/s10286-007-1005-zPMID: 18368304

Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.

Wang H, Ghosh A, Baigude H, Yang CS, Qiu L, Xia X, Zhou H, Rana TM, Xu Z.

J Biol Chem · 2008-03-26

DOI: 10.1074/jbc.m800834200PMID: 18367449

Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity.

Liang HL, Whelan HT, Eells JT, Wong-Riley MT.

Neuroscience · 2008-03-26

DOI: 10.1016/j.neuroscience.2008.03.042PMID: 18440709

Therapeutic cloning in individual parkinsonian mice.

Tabar V, Tomishima M, Panagiotakos G, Wakayama S, Menon J, Chan B, Mizutani E, Al-Shamy G, Ohta H, Wakayama T, Studer L.

Nat Med · 2008-03-23

DOI: 10.1038/nm1732PMID: 18376409

Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight.

Sharma JC, Ross IN, Rascol O, Brooks D.

Eur J Neurol · 2008-03-18

DOI: 10.1111/j.1468-1331.2008.02106.xPMID: 18355302

METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES USING NMDA RECEPTOR GLYCINE SITE ANTAGONISTS

ABELIOVICH ASA.

· 2008-03-17

System and method for using platelet biomarkers for diagnosis and treatment of neuro-psychiatric conditions

JASUJA SANJAY.

· 2008-03-14